Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $490.00 at Piper Sandler

Intuitive Surgical (NASDAQ:ISRG) had its target price increased by Piper Sandler from $435.00 to $490.00 in a research report report published on Tuesday morning, Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock.

Other equities analysts also recently issued research reports about the company. Stifel Nicolaus increased their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a buy rating in a research report on Monday, April 8th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a hold rating in a research note on Friday, April 19th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an outperform rating for the company in a research report on Friday, April 19th. Evercore ISI lifted their target price on shares of Intuitive Surgical from $385.00 to $425.00 and gave the company an in-line rating in a research report on Tuesday, July 2nd. Finally, BTIG Research boosted their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a buy rating in a research note on Friday, April 19th. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus price target of $410.32.

Intuitive Surgical Trading Down 0.3 %

Intuitive Surgical stock opened at $443.50 on Tuesday. The firm has a market cap of $157.31 billion, a PE ratio of 80.05, a P/E/G ratio of 5.74 and a beta of 1.39. Intuitive Surgical has a 12 month low of $254.85 and a 12 month high of $449.00. The stock’s 50 day simple moving average is $415.83 and its two-hundred day simple moving average is $389.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s revenue was up 11.5% on a year-over-year basis. During the same quarter last year, the business earned $1.00 earnings per share. On average, equities research analysts forecast that Intuitive Surgical will post 4.8 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the sale, the executive vice president now owns 298 shares in the company, valued at approximately $110,456.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,956 shares of company stock worth $6,927,011. 0.80% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently bought and sold shares of ISRG. Baystate Wealth Management LLC increased its stake in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 45 shares during the period. Creekmur Asset Management LLC grew its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares in the last quarter. MCF Advisors LLC increased its position in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the period. Headinvest LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at $28,000. Finally, Able Wealth Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at $28,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.